GSK at CHEST 2020
Research and innovation are at the heart of everything we do. We have been a leader in respiratory medicine for more than 50 years and continue to strengthen and broaden our understanding of diseases to deliver practice-changing medicine to those who need it. With eight ongoing research programs and six new medicine launches in five years, we are committed to delivering world-class treatments to help those around the world breathe better.
At this year’s CHEST Annual Meeting, we are proud to be sponsoring 19 data presentations which showcase our portfolio of medicines and ongoing efforts to provide a targeted and personalized treatment approach to those living with respiratory diseases. Follow GSK throughout CHEST 2020 or use the hashtag #ScienceOnTheSofa to join the conversation.
Our Respiratory Data Presentations at CHEST 2020
Click here for more on what you’ll see from GSK during the virtual CHEST Conference program and how to participate.
Our Disease Areas of Focus
We are committed to researching and developing solutions to help people living with challenging respiratory diseases breathe easier.
Our approach to Respiratory R&D
We believe in a personalized approach to care that defines our world-class research and development strategy.
GSK US Medical Affairs
This medical information is intended only for healthcare professionals registered to practice in the United States.
Follow us on Twitter @GSKUS for the latest updates!
#Cancer doesn’t stop because of a pandemic. Our own Michael Petroutsas RPh, SVP, US Oncology, discussed 4 ways the #COVID19 pandemic has changed #oncology for good, & how our teams quickly adapted to continue putting patients first. gsk.to/3o3pzixabout 3 days ago
#HCPs: Do your 50+ patients know that they are at risk of developing #shingles, even if they are healthy and active? Find resources to share with your patients on our #ShinglesDoesntPlayFavorites page: 👉gsk.to/3qt44tpd Jjabout 3 days ago